Skip to main content
Skip to main content
ACCD logo

Accolade, Inc. (ACCD) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

DELISTED 2025

What happened to Accolade, Inc. (ACCD) stock?

Accolade, Inc. (ACCD) no longer trades on public markets. It was delisted in April 2025. The figures below are historical and are not a current quote.

MCap: $576M| Vol: 4.54M|

Market cap $576M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Accolade, Inc. (ACCD). Accolade, Inc. provides technology-enabled healthcare solutions, helping individuals navigate the complexities of the healthcare system and workplace benefits. The company's platform offers personalized support through health assistants and clinicians, aiming to improve healthcare utilization and outcomes.

Last analyzed: Sep 9, 2026

Accolade, Inc. provides technology-enabled healthcare solutions, helping individuals navigate the complexities of the healthcare system and workplace benefits. The company's platform offers personalized support through health assistants and clinicians, aiming to improve healthcare utilization and outcomes.

Analyst Coverage for ACCD: ACCD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ACCD against sector peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the ACCD film Every key number, told as a short cinematic story — just press play. ~2 min

Dated analysis: the newest financial statements on file are 21 months old (Nov 30, 2024), so the figures and score below describe that period, not today.

Council Score · Weighted Average of 3 Disciplines
Split View 41/100 · C

ACCD: 1/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Accolade, Inc. Company Overview

Data Provenance | Financial Data Quantitative Analysis

Research confidence

Low 3/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price 11 days old
  • Latest filing 609 days ago
  • No analyst coverage

How Accolade, Inc. Is Valued

Accolade, Inc. carries a market capitalization of $576M, placing it in the small-cap category.

Accolade, Inc. Financial Trajectory

Accolade, Inc. (ACCD) reported $105.1M in revenue for Q3 FY2025, a decline of 1.2% compared to the prior quarter. The company recorded a net loss of $121.3M, with diluted EPS of $-1.50. Revenue has contracted over three consecutive quarters, which investors in this small-cap its sector stock should monitor closely. Across the four most recent quarters, ACCD averaged $-0.56 in diluted EPS.

ACCD Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 FY2025 $105M -$121M -$1.50
Q2 FY2025 $106M -$24M -$0.30
Q1 FY2025 $110M -$28M -$0.35
Q4 FY2024 $125M -$8M -$0.10

Q3 FY2025 · filed 10 Jan 2025 · SEC EDGAR →

Based on FMP financials and quantitative analysis

ACCD Latest News

No recent news available for ACCD.

What Investors Ask About Accolade, Inc. (ACCD)

What happened to Accolade, Inc. (ACCD) stock?

Accolade, Inc. (ACCD) no longer trades on public markets. It was delisted in April 2025. The figures below are historical and are not a current quote.

Can I still buy ACCD shares?

No. ACCD stopped trading on public markets in April 2025, so the shares are not available through a broker. Anything you see quoted for ACCD elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before ACCD stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Accolade, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

More Stocks We Cover